CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 28 enrolled
Drug / intervention
Ezetimibedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00376246
NCT00376246Phase 4Completed
CompareCT.gov

Effect of Ezetimibe on Flow-mediated Brachial Artery Reactivity in Healthy Subjects

University of California, San Diego·interventional·Posted Sep 14, 2006·Updated Feb 12, 2020

In Brief

A Phase 4 clinical trial evaluating Ezetimibe for Endothelial Dysfunction. Completed, enrolled 28 participants.

Detailed Summary

The objective of this study is to show that Ezetimibe will improve endothelial function following high cholesterol meals in healthy subjects by decreasing absorption of cholesterol and thus affecting concentration and composition of remnant-like particles.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEndothelial Dysfunction
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 14, 2006
Enrollment StartSep 1, 2006
Primary CompletionApr 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 19.8 years ago

Interventions

Ezetimibedrug